$0.3751
-0.0199-5.04%
Last update: Nov 10, 8:59 AM
Redhill Biopharma Ltd
RDHLNASDAQ
Redhill Biopharma fell 64.9% from $1.07 to $0.38, behind the S&P 500's +10.0%. Its worst day was Jun 9 (−21.6%), and its low came Nov 10 at $0.38.
Nov 10, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Redhill Biopharma closed at its highest level of the year, 30.8% above where the year started.
+35.9% · S&P 500 +0.7%
Story events cover the past 12 months · Times ET
EPS of $0.00 was reported on $286,000.00 revenue.
+1.0% · S&P 500 +0.2%
Redhill Biopharma shares fell 21.6%, while the S&P 500 fell 0.3%.
−21.6%, the year's worst day · S&P 500 −0.3%
Redhill Biopharma shares rose 38.0%, while the S&P 500 fell 0.3%.
+38.0%, the year's best day, on 104M shares, the year's heaviest volume · S&P 500 −0.3%
EPS of $0.00 was reported on $0.00 revenue.
0.0% · S&P 500 +0.2%
Where it ended: a close of $0.38 on Nov 10, 2026.
Nothing in the past 12 months.
All RDHL analyst actionsNothing in the past 12 months.
All RDHL dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for RDHL and SPY from Benzinga historical bars. Not investment advice.
